📊 Score Breakdown
Offering Ability
20
Cash Runway
95
Float Risk
37
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
64%
🔄 Reverse Split
70%
• 50-day avg $0.70 below $1 exchange minimum
• Only 1 months cash — financial pressure
🔁 Convertible Conversion
60%
• Major convertible overhang: 90% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise
55%
• Critical: only 1.4 months cash remaining
💹 Market Data
Market Cap$13.10M
Shares Outstanding18.74M
Float13.15M
Cash$1.24M
Debt$63.28M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 20.5% shares (2025Q4 vs prior)
18 institutional holders · 2.75M shares
#1
Ibex Investors LLC
1.84M shares
#2
Zimmer Partners, LP
581.2K shares
#3
Virtu Financial LLC
62.3K shares
+ 15 more holders Sign up free to view →
📉 Short Interest
Short Interest136.1K
Days to Cover1.0
% of Float1.0%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Apr 24, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2024
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for GAUZ
📊 GAUZ FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 GAUZ Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.